Healthcare & Life Sciences
6Ban
United Kingdom
About
6Ban develops microbiome-based therapeutics using anaerobic spore-forming bacteria to treat gastrointestinal diseases.
Explore 6Ban's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.